The DOI matches its Crossref record; 226 of the 226 references it cites were found in a registry or an index.
Epidemiology of Glioblastoma Multiforme–Literature Review
Open accessAbstract
Glioblastoma multiforme (GBM) is one of the most aggressive malignancies, with a median overall survival of approximately 15 months. In this review, we analyze the pathogenesis of GBM, as well as epidemiological data, by age, gender, and tumor location. The data indicate that GBM is the higher-grade primary brain tumor and is significantly more common in men. The risk of being diagnosed with glioma increases with age, and median survival remains low, despite medical advances. In addition, it is difficult to determine clearly how GBM is influenced by stimulants, certain medications (e.g., NSAIDs), cell phone use, and exposure to heavy metals.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Radiotherapy Plus Concomitant and Adjuvant Temozolomide for Glioblastoma
Stupp, R., Mason, W. P., van den Bent, M. J., Weller, M., Fisher, B., Taphoorn, M. J. B., Belanger, K., Brandes, A. A., Marosi, C., Bogdahn, U., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043330 · Cited by 21,807
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
Louis, D. N., Perry, A., Reifenberger, G., von Deimling, A., Figarella-Branger, D., Cavenee, W. K., Ohgaki, H., Wiestler, O. D., Kleihues, P., & Ellison, D. W. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1545-1 · Cited by 15,657
The 2021 WHO classification of tumors of the central nervous system: a summary
Louis, D. N., Perry, A., Wesseling, P., Brat, D. J., Cree, I. A., Figarella-Branger, D., Hawkins, C., Ng, H. K., Pfister, S. M., Reifenberger, G., et al. (2021) · Neuro-Oncology · doi:10.1093/neuonc/noab106 · Cited by 12,273
Ostrom, Q. T., Gittleman, H., Farah, P., Ondracek, A., Chen, Y., Wolinsky, Y., Stroup, N. E., Kruchko, C., & Barnholtz-Sloan, J. S. (2013) · Neuro-Oncology · doi:10.1093/neuonc/not151 · Cited by 11,994
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
The Cancer Genome Atlas Research Network (2008) · Nature · doi:10.1038/nature07385 · Cited by 7,735 · cited 1×
“In addition, the high heterogeneity of GBM documented in the Cancer Genome Atlas (TCGA) [127,128] and its intricacy may influence the different responses of different tumor subtypes to NSAIDs and result in discrepancies.”
MGMT Gene Silencing and Benefit from Temozolomide in Glioblastoma
Hegi, M. E., Diserens, A.-C., Gorlia, T., Hamou, M.-F., de Tribolet, N., Weller, M., Kros, J. M., Hainfellner, J. A., Mason, W., Mariani, L., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043331 · Cited by 7,405
Origin and physiological roles of inflammation
Medzhitov, R. (2008) · Nature · doi:10.1038/nature07201 · Cited by 6,618 · cited 1×
“A molecular mechanism that facilitates this process is inflammation [224].”
The Somatic Genomic Landscape of Glioblastoma
Brennan, C. W., Verhaak, R. G. W., McKenna, A., Campos, B., Noushmehr, H., Salama, S. R., Zheng, S., Chakravarty, D., Sanborn, J. Z., Berman, S. H., et al. (2013) · Cell · doi:10.1016/j.cell.2013.09.034 · Cited by 5,016
Pearce, M. S., Salotti, J. A., Little, M. P., McHugh, K., Lee, C., Kim, K. P., Howe, N. L., Ronckers, C. M., Rajaraman, P., Craft, A. W., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60815-0 · Cited by 3,735
The complexity of NF-κB signaling in inflammation and cancer
Hoesel, B., & Schmid, J. A. (2013) · Molecular Cancer · doi:10.1186/1476-4598-12-86 · Cited by 3,165
MAP kinase signalling pathways in cancer
Dhillon, A. S., Hagan, S., Rath, O., & Kolch, W. (2007) · Oncogene · doi:10.1038/sj.onc.1210421 · Cited by 2,995
Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma
Schwartzentruber, J., Korshunov, A., Liu, X.-Y., Jones, D. T. W., Pfaff, E., Jacob, K., Sturm, D., Fontebasso, A. M., Quang, D.-A. K., Tönjes, M., et al. (2012) · Nature · doi:10.1038/nature10833 · Cited by 2,631 · cited 1×
“3 to be incorporated into heterochromatin [33].”
Adipose tissue, adipokines, and inflammation
Fantuzzi, G. (2005) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2005.02.023 · Cited by 2,606 · cited 1×
“5 kg/m2) at age 21 is associated with a lower risk of developing gliomas later in life, although the results were only statistically significant in the group of women [177].”
Glioma Groups Based on 1p/19q,IDH, and TERT Promoter Mutations in Tumors
Eckel-Passow, J. E., Lachance, D. H., Molinaro, A. M., Walsh, K. M., Decker, P. A., Sicotte, H., Pekmezci, M., Rice, T., Kosel, M. L., Smirnov, I. V., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1407279 · Cited by 1,982
Ostrom, Q. T., Gittleman, H., Liao, P., Vecchione-Koval, T., Wolinsky, Y., Kruchko, C., & Barnholtz-Sloan, J. S. (2017) · Neuro-Oncology · doi:10.1093/neuonc/nox158 · Cited by 1,800
Wang, D., & DuBois, R. N. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2809 · Cited by 1,793
Ostrom, Q. T., Patil, N., Cioffi, G., Waite, K., Kruchko, C., & Barnholtz-Sloan, J. S. (2020) · Neuro-Oncology · doi:10.1093/neuonc/noaa200 · Cited by 1,789
Killela, P. J., Reitman, Z. J., Jiao, Y., Bettegowda, C., Agrawal, N., Diaz, L. A., Friedman, A. H., Friedman, H., Gallia, G. L., Giovanella, B. C., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1303607110 · Cited by 1,368
Tobacco smoke and involuntary smoking.
(2004) · PubMed · Cited by 1,360
Malmström, A., Grønberg, B. H., Marosi, C., Stupp, R., Frappaz, D., Schultz, H., Abacioglu, U., Tavelin, B., Lhermitte, B., Hegi, M. E., et al. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70265-6 · Cited by 1,286
Genetic Pathways to Glioblastoma
Ohgaki, H., Dessen, P., Jourde, B., Horstmann, S., Nishikawa, T., Di Patre, P.-L., Burkhard, C., Schüler, D., Probst-Hensch, N. M., Maiorka, P. C., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1337 · Cited by 1,270
The Definition of Primary and Secondary Glioblastoma
Ohgaki, H., & Kleihues, P. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-3002 · Cited by 1,132
Neurotoxic Effects and Biomarkers of Lead Exposure: A Review
Sanders, T., Liu, Y., Buchner, V., & Tchounwou, P. B. (2009) · Reviews on Environmental Health · doi:10.1515/reveh.2009.24.1.15 · Cited by 1,076
Fang, M., Wang, Y., Ai, N., Hou, Z., Sun, Y., Lu, H., Welsh, W. J., & Yang, C. S. (2003) · PubMed · Cited by 1,049
Cancer prevention by tea: animal studies, molecular mechanisms and human relevance
Yang, C. S., Wang, X., Lu, G., & Picinich, S. C. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2641 · Cited by 995
The use and control of nitrate and nitrite for the processing of meat products
Honikel, K.-O. (2008) · Meat Science · doi:10.1016/j.meatsci.2007.05.030 · Cited by 956
Tumors of the Brain and Nervous System after Radiotherapy in Childhood
Ron, E., Modan, B., Boice, J. D., Alfandary, E., Stovall, M., Chetrit, A., & Katz, L. (1988) · New England Journal of Medicine · doi:10.1056/nejm198810203191601 · Cited by 934
Wang, D. (2006) · Gut · doi:10.1136/gut.2004.047100 · Cited by 899
TP53 mutations in human cancers: Functional selection and impact on cancer prognosis and outcomes
Petitjean, A., Achatz, M. I. W., Borresen-Dale, A. L., Hainaut, P., & Olivier, M. (2007) · Oncogene · doi:10.1038/sj.onc.1210302 · Cited by 884
Carcinogenicity of radiofrequency electromagnetic fields
Baan, R., Grosse, Y., Lauby-Secretan, B., El Ghissassi, F., Bouvard, V., Benbrahim-Tallaa, L., Guha, N., Islami, F., Galichet, L., & Straif, K. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70147-4 · Cited by 837
Estrogen production and action
Nelson, L. R., & Bulun, S. E. (2001) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2001.117432 · Cited by 834
WHO 2016 Classification of gliomas
Wesseling, P., & Capper, D. (2018) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12432 · Cited by 795
A Mutant-p53/Smad Complex Opposes p63 to Empower TGFβ-Induced Metastasis
Adorno, M., Cordenonsi, M., Montagner, M., Dupont, S., Wong, C., Hann, B., Solari, A., Bobisse, S., Rondina, M. B., Guzzardo, V., et al. (2009) · Cell · doi:10.1016/j.cell.2009.01.039 · Cited by 782
Juul, A. (1994) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.78.3.744 · Cited by 776
High-grade glioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Stupp, R., Brada, M., van den Bent, M. J., Tonn, J.-C., & Pentheroudakis, G. (2014) · Annals of Oncology · doi:10.1093/annonc/mdu050 · Cited by 772
Mutant p53 Gain-of-Function in Cancer
Oren, M., & Rotter, V. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a001107 · Cited by 753
D'Mello, C., Le, T., & Swain, M. G. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.3567-08.2009 · Cited by 675
The INTERPHONE Study Group (2010) · International Journal of Epidemiology · doi:10.1093/ije/dyq079 · Cited by 657
Smith, J. S., Tachibana, I., Passe, S. M., Huntley, B. K., Borell, T. J., Iturria, N., O'Fallon, J. R., Schaefer, P. L., Scheithauer, B. W., James, C. D., et al. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.16.1246 · Cited by 630
Ekstrand, A. J., Sugawa, N., James, C. D., & Collins, V. P. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.10.4309 · Cited by 602
Murata, M. (2018) · Environmental Health and Preventive Medicine · doi:10.1186/s12199-018-0740-1 · Cited by 588
Frequent ATRX , CIC , FUBP1 and IDH1 mutations refine the classification of malignant gliomas
Jiao, Y., Killela, P. J., Reitman, Z. J., Rasheed, B. A., Heaphy, C. M., de Wilde, R. F., Rodriguez, F. J., Rosemberg, S., Oba-Shinjo, S. M., Nagahashi Marie, S. K., et al. (2012) · Oncotarget · doi:10.18632/oncotarget.588 · Cited by 584
Inoue, K., Sugiyama, H., Ogawa, H., Nakagawa, M., Yamagami, T., Miwa, H., Kita, K., Hiraoka, A., Masaoka, T., & Nasu, K. (1994) · Blood · doi:10.1182/blood.v84.9.3071.3071 · Cited by 575
DNA damage induced by chronic inflammation contributes to colon carcinogenesis in mice
Meira, L. B., Bugni, J. M., Green, S. L., Lee, C.-W., Pang, B., Borenshtein, D., Rickman, B. H., Rogers, A. B., Moroski-Erkul, C. A., McFaline, J. L., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci35073 · Cited by 548
p53 controls cancer cell invasion by inducing the MDM2-mediated degradation of Slug
Wang, S.-P., Wang, W.-L., Chang, Y.-L., Wu, C.-T., Chao, Y.-C., Kao, S.-H., Yuan, A., Lin, C.-W., Yang, S.-C., Chan, W.-K., et al. (2009) · Nature Cell Biology · doi:10.1038/ncb1875 · Cited by 493
Improved survival time trends for glioblastoma using the SEER 17 population-based registries
Koshy, M., Villano, J. L., Dolecek, T. A., Howard, A., Mahmood, U., Chmura, S. J., Weichselbaum, R. R., & McCarthy, B. J. (2012) · Journal of Neuro-Oncology · doi:10.1007/s11060-011-0738-7 · Cited by 481
A Review on a Deep Learning Perspective in Brain Cancer Classification
Tandel, G. S., Biswas, M., Kakde, O. G., Tiwari, A., Suri, H. S., Turk, M., Laird, J., Asare, C., Ankrah, A. A., Khanna, N. N., et al. (2019) · Cancers · doi:10.3390/cancers11010111 · Cited by 466
Glioblastoma Multiforme, Diagnosis and Treatment; Recent Literature Review
Batash, R., Asna, N., Schaffer, P., Francis, N., & Schaffer, M. (2017) · Current Medicinal Chemistry · doi:10.2174/0929867324666170516123206 · Cited by 436
Lai, A., Kharbanda, S., Pope, W. B., Tran, A., Solis, O. E., Peale, F., Forrest, W. F., Pujara, K., Carrillo, J. A., Pandita, A., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.33.8715 · Cited by 433
Liu, X.-Y., Gerges, N., Korshunov, A., Sabha, N., Khuong-Quang, D.-A., Fontebasso, A. M., Fleming, A., Hadjadj, D., Schwartzentruber, J., Majewski, J., et al. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-1031-3 · Cited by 428
Cafestol and Kahweol, Two Coffee Specific Diterpenes with Anticarcinogenic Activity
Cavin, C., Holzhaeuser, D., Scharf, G., Constable, A., Huber, W. W., & Schilter, B. (2002) · Food and Chemical Toxicology · doi:10.1016/s0278-6915(02)00029-7 · Cited by 422
Incidence of gliomas by anatomic location
Larjavaara, S., Mäntylä, R., Salminen, T., Haapasalo, H., Raitanen, J., Jääskeläinen, J., & Auvinen, A. (2007) · Neuro-Oncology · doi:10.1215/15228517-2007-016 · Cited by 396
A pilot clinical study of Δ9-tetrahydrocannabinol in patients with recurrent glioblastoma multiforme
Guzmán, M., Duarte, M. J., Blázquez, C., Ravina, J., Rosa, M. C., Galve-Roperh, I., Sánchez, C., Velasco, G., & González-Feria, L. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603236 · Cited by 365
Role of immune cells in the removal of deleterious senescent cells
Kale, A., Sharma, A., Stolzing, A., Desprez, P.-Y., & Campisi, J. (2020) · Immunity & Ageing · doi:10.1186/s12979-020-00187-9 · Cited by 351
The role of JAK-STAT signaling within the CNS
Nicolas, C. S., Amici, M., Bortolotto, Z. A., Doherty, A., Csaba, Z., Fafouri, A., Dournaud, P., Gressens, P., Collingridge, G. L., & Peineau, S. (2013) · JAK-STAT · doi:10.4161/jkst.22925 · Cited by 351
Wiestler, B., Capper, D., Holland-Letz, T., Korshunov, A., von Deimling, A., Pfister, S. M., Platten, M., Weller, M., & Wick, W. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1156-z · Cited by 346
Gene expression profiling and genetic markers in glioblastoma survival
Rich, J. N., Hans, C., Jones, B., Iversen, E. S., McLendon, R. E., Rasheed, B. K. A., Dobra, A., Dressman, H. K., Bigner, D. D., Nevins, J. R., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3936 · Cited by 316
PTEN function: the long and the short of it
Hopkins, B. D., Hodakoski, C., Barrows, D., Mense, S. M., & Parsons, R. E. (2014) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2014.02.006 · Cited by 309 · cited 1×
“The PI3K/Akt pathway is blocked by PTEN, and loss of functional PTEN impairs the regulation of cell survival, cell growth, and proliferation [84].”
Histologic classification of gliomas
(2016) · Handbook of Clinical Neurology · doi:10.1016/b978-0-12-802997-8.00005-0 · Cited by 297
Fredriksson, N. J., Ny, L., Nilsson, J. A., & Larsson, E. (2014) · Nature Genetics · doi:10.1038/ng.3141 · Cited by 289
Simmons, M. L., Lamborn, K. R., Takahashi, M., Chen, P.-Y., Israel, M. A., Berger, M. S., Godfrey, T. E., Nigro, J. M., Prados, M. D., Chang, S. M., et al. (2001) · PubMed · Cited by 278
Atopy and Risk of Brain Tumors: A Meta-analysis
Linos, E., Raine, T., Alonso, A., & Michaud, D. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djm170 · Cited by 275
Immune Evasion Strategies of Glioblastoma
Razavi, S.-M., Lee, K. E., Jin, B. E., Aujla, P. S., Gholamin, S., & Li, G. (2016) · Frontiers in Surgery · doi:10.3389/fsurg.2016.00011 · Cited by 262
Schlehofer, B., Blettner, M., Preston-Martin, S., Niehoff, D., Wahrendorf, J., Arslan, A., Ahlbom, A., Choi, W. N., Giles, G. G., Howe, G. R., et al. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19990719)82:2<155::aid-ijc1>3.0.co;2-p · Cited by 242
The natural history of EGFR and EGFRvIII in glioblastoma patients
Heimberger, A. B., Suki, D., Yang, D., Shi, W., & Aldape, K. (2005) · Journal of Translational Medicine · doi:10.1186/1479-5876-3-38 · Cited by 235
PTEN Signaling pathways in glioblastoma
Koul, D. (2008) · Cancer Biology & Therapy · doi:10.4161/cbt.7.9.6954 · Cited by 228
Glioblastoma in England: 2007–2011
Brodbelt, A., Greenberg, D., Winters, T., Williams, M., Vernon, S., & Collins, V. P. (2015) · European Journal of Cancer · doi:10.1016/j.ejca.2014.12.014 · Cited by 227
Mutator activity induced by microRNA-155 ( miR-155 ) links inflammation and cancer
Tili, E., Michaille, J.-J., Wernicke, D., Alder, H., Costinean, S., Volinia, S., & Croce, C. M. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1101795108 · Cited by 227
Faury, D., Nantel, A., Dunn, S. E., Guiot, M.-C., Haque, T., Hauser, P., Garami, M., Bognár, L., Hanzély, Z., Liberski, P. P., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.07.8626 · Cited by 225
(2017) · Codon Publications eBooks · doi:10.15586/codon.glioblastoma.2017 · Cited by 220
Coffee consumption and the risk of cancer: An overview
Nkondjock, A. (2009) · Cancer Letters · doi:10.1016/j.canlet.2008.08.022 · Cited by 216
Changing incidence and improved survival of gliomas
Ho, V. K. Y., Reijneveld, J. C., Enting, R. H., Bienfait, H. P., Robe, P., Baumert, B. G., & Visser, O. (2014) · European Journal of Cancer · doi:10.1016/j.ejca.2014.05.019 · Cited by 215
Interleukins in glioblastoma pathophysiology: implications for therapy
Yeung, Y., McDonald, K., Grewal, T., & Munoz, L. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12008 · Cited by 210
Survival comparison between glioblastoma multiforme and other incurable cancers
Tran, B., & Rosenthal, M. A. (2010) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2009.09.004 · Cited by 210
Nasal toxicity, carcinogenicity, and olfactory uptake of metals.
Sunderman, F. W. (2001) · PubMed · Cited by 206
Current Trends in Targeted Therapies for Glioblastoma Multiforme
Ohka, F., Natsume, A., & Wakabayashi, T. (2012) · Neurology Research International · doi:10.1155/2012/878425 · Cited by 200
A population‐based description of glioblastoma multiforme in Los Angeles County, 1974–1999
Chakrabarti, I., Cockburn, M., Cozen, W., Wang, Y., & Preston‐Martin, S. (2005) · Cancer · doi:10.1002/cncr.21539 · Cited by 199
Kang, S. S., Han, K.-S., Ku, B. M., Lee, Y. K., Hong, J., Shin, H. Y., Almonte, A. G., Woo, D. H., Brat, D. J., Hwang, E. M., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-2886 · Cited by 197
Teo, G. S. L., Ankrum, J. A., Martinelli, R., Boetto, S. E., Simms, K., Sciuto, T. E., Dvorak, A. M., Karp, J. M., & Carman, C. V. (2012) · STEM CELLS · doi:10.1002/stem.1198 · Cited by 196
Knobbe, C. B., Merlo, A., & Reifenberger, G. (2002) · Neuro-Oncology · doi:10.1093/neuonc/4.3.196 · Cited by 186
Newcomb, E. W., Cohen, H., Lee, S. R., Bhalla, S. K., Bloom, J., Hayes, R. L., & Miller, D. C. (1998) · Brain Pathology · doi:10.1111/j.1750-3639.1998.tb00191.x · Cited by 179
Marcu, J. P., Christian, R. T., Lau, D., Zielinski, A. J., Horowitz, M. P., Lee, J., Pakdel, A., Allison, J., Limbad, C., Moore, D. H., et al. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0407 · Cited by 173
Philips, A., Henshaw, D. L., Lamburn, G., & O’Carroll, M. J. (2018) · Journal of Environmental and Public Health · doi:10.1155/2018/7910754 · Cited by 165
Current understanding of the role and targeting of tumor suppressor p53 in glioblastoma multiforme
England, B., Huang, T., & Karsy, M. (2013) · Tumor Biology · doi:10.1007/s13277-013-0871-3 · Cited by 163
Risk of Brain Tumors Associated with Exposure to Exogenous Female Sex Hormones
Wigertz, A., Lönn, S., Mathiesen, T., Ahlbom, A., Hall, P., & Feychting, M. (2006) · American Journal of Epidemiology · doi:10.1093/aje/kwj254 · Cited by 163
Hernández-Tiedra, S., Fabriàs, G., Dávila, D., Salanueva, Í. J., Casas, J., Montes, L. R., Antón, Z., García-Taboada, E., Salazar-Roa, M., Lorente, M., et al. (2016) · Autophagy · doi:10.1080/15548627.2016.1213927 · Cited by 160
Inhibition of DNA repair for sensitizing resistant glioma cells to temozolomide
Kanzawa, T., Bedwell, J. R., Kondo, Y., Kondo, S., & Germano, I. M. (2003) · Journal of neurosurgery · doi:10.3171/jns.2003.99.6.1047 · Cited by 155
Louis, D. N., Aldape, K. D., Brat, D. J., Capper, D., Ellison, D. W., Hawkins, C. E., Paulus, W., Perry, A., Reifenberger, G., Figarella-Branger, D. F., et al. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1646-x · Cited by 155
Vemurafenib in pediatric patients with BRAFV 600E mutated high‐grade gliomas
Bautista, F. J., Paci, A., Minard‐Colin, V., Dufour, C., Grill, J., Lacroix, L., Varlet, P., Valteau‐Couanet, D., & Geoerger, B. (2013) · Pediatric Blood & Cancer · doi:10.1002/pbc.24891 · Cited by 148
Impact of gender on the survival of patients with glioblastoma
Tian, M., Ma, W., Chen, Y., Yu, Y., Zhu, D., Shi, J., & Zhang, Y. (2018) · Bioscience Reports · doi:10.1042/bsr20180752 · Cited by 147
Knobbe-Thomsen, C. B. (2002) · Neuro-Oncology · doi:10.1215/15228517-4-3-196 · Cited by 146
TERT promoter mutations and polymorphisms as prognostic factors in primary glioblastoma
Mosrati, M. A., Malmström, A., Łysiak, M., Krysztofiak, A., Hallbeck, M., Milos, P., Hallbeck, A., Bratthäll, C., Strandéus, M., Stenmark‐Askmalm, M., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.4389 · Cited by 145
Insulin-like growth factor binding protein 2 promotes glioma development and progression
Dunlap, S. M., Celestino, J., Wang, H., Jiang, R., Holland, E. C., Fuller, G. N., & Zhang, W. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0703145104 · Cited by 143
Telomerase promoter mutations in cancer: an emerging molecular biomarker?
Vinagre, J., Pinto, V. S., Celestino, R., Reis, M., Pópulo, H., Boaventura, P., Melo, M., Catarino, T. A., Lima, J. P., Lopes, J. M., et al. (2014) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-014-1608-4 · Cited by 142
Interleukin-6 gene amplification and shortened survival in glioblastoma patients
Tchirkov, A., Khalil, T. A., Chautard, E., Mokhtari, K., Véronèse, L., Irthum, B., Vago, P., Kemeny, J., & Verrelle, P. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603586 · Cited by 140
Spiegl‐Kreinecker, S., Lötsch, D., Ghanim, B., Pirker, C., Mohr, T. T., Laaber, M., Weis, S., Olschowski, A., Webersinke, G., Pichler, J., et al. (2015) · Neuro-Oncology · doi:10.1093/neuonc/nov010 · Cited by 140
Nabors, B., Suswam, E. A., Huang, Y., Yang, X., Johnson, M. J., & King, P. H. (2003) · PubMed · Cited by 139
Michaud, D. S., Gallo, V., Schlehofer, B., Tjønneland, A. M., Olsen, A., Overvad, K., Dahm, C. C., Kaaks, R., Lukanova, A., Boeing, H., et al. (2010) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-10-0447 · Cited by 137
TERT Promoter Alterations in Glioblastoma: A Systematic Review
Olympios, N., Gilard, V., Marguet, F., Clatot, F., Fiore, F. D., & Fontanilles, M. (2021) · Cancers · doi:10.3390/cancers13051147 · Cited by 137
Incidence of intracranial tumors following hospitalization for head injuries (Denmark)
Inskip, P. D., Mellemkjær, L., Gridley, G., & Olsen, J. H. (1998) · Cancer Causes & Control · doi:10.1023/a:1008861722901 · Cited by 136
Khurana, V. G., Jain, S., Smee, R., Cook, R., Dobes, M., Shadbolt, B., Smith, S., & Dexter, M. A. J. (2011) · Surgical Neurology International · doi:10.4103/2152-7806.90696 · Cited by 134
An international case-control study of adult glioma and meningioma: the role of head trauma
Preston‐Martin, S. (1998) · International Journal of Epidemiology · doi:10.1093/ije/27.4.579 · Cited by 133
Role of melatonin in cancer treatment.
Cutando, A., López‐Valverde, A., Arias‐Santiago, S., de Vicente, J., & de Diego, R. G. (2012) · PubMed · Cited by 130
Lissoni, P., Meregalli, S., Nosetto, L., Barni, S., Tancini, G., Fossati, V., & Maestroni, G. (2009) · Oncology · doi:10.1159/000227533 · Cited by 130
Subsequent neoplasms of the CNS among survivors of childhood cancer: a systematic review
Bowers, D. C., Nathan, P. C., Constine, L. S., WOODMAN, C. L., Bhatia, R., Keller, K. L., & Bashore, L. M. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70107-4 · Cited by 127
Glioma incidence and survival variations by county‐level socioeconomic measures
Coté, D. J., Ostrom, Q. T., Gittleman, H. R., Duncan, K. R., CreveCoeur, T. S., Kruchko, C., Smith, T. R., Stampfer, M. J., & Barnholtz‐Sloan, J. S. (2019) · Cancer · doi:10.1002/cncr.32328 · Cited by 127
Liu, C., Chen, Z., Chen, K., Liao, F.-T., Chung, C.-E., Liu, X., Lin, Y., Keohavong, P., Leikauf, G. D., & Di, Y. P. (2020) · Cancer Research · doi:10.1158/0008-5472.can-20-1994 · Cited by 123
A TNF–JNK–Axl–ERK signaling axis mediates primary resistance to EGFR inhibition in glioblastoma
Guo, G., Gong, K., Ali, S., Ali, N., Shallwani, S., Hatanpaa, K. J., Pan, E., Mickey, B., Burma, S., Wang, D. H., et al. (2017) · Nature Neuroscience · doi:10.1038/nn.4584 · Cited by 122
THE DESCRIPTIVE EPIDEMIOLOGY OF PRIMARY INTRACRANIAL NEOPLASMS: THE CONNECTICUT EXPERIENCE
Schoenberg, B. S., Christine, B. W., & Whisnant, J. P. (1976) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a112322 · Cited by 121
Polymorphisms Associated with Asthma Are Inversely Related to Glioblastoma Multiforme
Schwartzbaum, J., Ahlbom, A., Malmer, B., Lönn, S., Brookes, A. J., Doss, H., Debinski, W., Henriksson, R., & Feychting, M. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3728 · Cited by 121
Survivorship in adults with malignant brain and other central nervous system tumor from 2000–2014
Gittleman, H. R., Boscia, A. L., Ostrom, Q. T., Truitt, G., Fritz, Y., Kruchko, C., & Barnholtz‐Sloan, J. S. (2018) · Neuro-Oncology · doi:10.1093/neuonc/noy090 · Cited by 119
Fibroblast Growth Factor Receptor Functions in Glioblastoma
Jimenez‐Pascual, A., & Siebzehnrübl, F. A. (2019) · Cells · doi:10.3390/cells8070715 · Cited by 118
Kore, R. A., & Abraham, E. C. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.09.068 · Cited by 117
Gain-of-Function (GOF) Mutant p53 as Actionable Therapeutic Target
Schulz‐Heddergott, R., & Moll, U. M. (2018) · Cancers · doi:10.3390/cancers10060188 · Cited by 117
Lu, T., Tian, L., Han, Y., Vogelbaum, M., & Stark, G. R. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0700118104 · Cited by 115
Soroceanu, L., Kharbanda, S., Chen, R., Soriano, R. H., Aldape, K., Misra, A., Zha, J., Forrest, W. F., Nigro, J. M., Modrusan, Z. D., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0611271104 · Cited by 114
Hardell, L., & Carlberg, M. (2015) · Pathophysiology · doi:10.1016/j.pathophys.2014.10.001 · Cited by 114
Fabbro-Péray, P., Zouaoui, S., Darlix, A., Fabbro, M., Pallud, J., Rigau, V., Mathieu‐Daudé, H., Bessaoud, F., Bauchet, F., Riondel, A., et al. (2018) · Journal of Neuro-Oncology · doi:10.1007/s11060-018-03065-z · Cited by 114
Mean daily intake of volatile N-nitrosamines from foods and beverages in West Germany in 1989–1990
Tricker, A. R., Pfundstein, B., Theobald, E., Preußmann, R., & Spiegelhalder, B. (1991) · Food and Chemical Toxicology · doi:10.1016/0278-6915(91)90180-f · Cited by 113
Height, Body Mass Index, and Physical Activity in Relation to Glioma Risk
Moore, S. C., Rajaraman, P., Dubrow, R., Darefsky, A. S., Koebnick, C., Hollenbeck, A. R., Schatzkin, A. G., & Leitzmann, M. F. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-1669 · Cited by 113
Frequency of BRAF V600E mutations in 969 central nervous system neoplasms
Behling, F., Barrantes‐Freer, A., Skardelly, M., Nieser, M., Christians, A., Stockhammer, F., Rohde, V., Tatagiba, M. S., Hartmann, C. J., Stadelmann, C., et al. (2016) · Diagnostic Pathology · doi:10.1186/s13000-016-0506-2 · Cited by 112
Kim, S., Domon–Dell, C., Kang, J., Chung, D. H., Freund, J., & Evers, B. M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m308383200 · Cited by 110
Pediatric glioblastomas: A histopathological and molecular genetic study
Suri, V. S., Das, P., Jain, A., Sharma, M. C., Borkar, S. A., Suri, A., Gupta, D. K., & Sarkar, C. (2008) · Neuro-Oncology · doi:10.1215/15228517-2008-092 · Cited by 110
Polymorphisms Associated with Asthma Are Inversely Related to Glioblastoma Multiforme
Blakely, J. A. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3200 · Cited by 108
Gain of Function of Mutant TP53 in Glioblastoma: Prognosis and Response to Temozolomide
Wang, X., Chen, J., Liu, J., You, C., Liu, Y., & Mao, Q. (2013) · Annals of Surgical Oncology · doi:10.1245/s10434-013-3380-0 · Cited by 106
Aberrant Expression of Interleukin-1β and Inflammasome Activation in Human Malignant Gliomas
Tarassishin, L., Casper, D., & Lee, S. C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0103432 · Cited by 105
History of allergies and risk of glioma in adults
Schoemaker, M. J., Swerdlow, A. J., Hepworth, S. J., McKinney, P. A., van Tongeren, M., & Muir, K. R. (2006) · International Journal of Cancer · doi:10.1002/ijc.22091 · Cited by 105
Long-term Anti-inflammatory and Antihistamine Medication Use and Adult Glioma Risk
Scheurer, M. E., El‐Zein, R. A., Thompson, P. A., Aldape, K., Levin, V. A., Gilbert, M. R., Weinberg, J. S., & Bondy, M. L. (2008) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-07-2621 · Cited by 103
Association Between Prediagnostic IgE Levels and Risk of Glioma
Schwartzbaum, J., Ding, B., Johannesen, T. B., Osnes, L., Karavodin, L. M., Ahlbom, A., Feychting, M., & Grimsrud, T. K. (2012) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djs315 · Cited by 102
Kraus, J. A., Glesmann, N., Beck, M., Krex, D., Klockgether, T., Schackert, G., & Schlegel, U. (2000) · Journal of Neuro-Oncology · doi:10.1023/a:1006402614838 · Cited by 100
Brain tumors and hormonal factors: review of the epidemiological literature
Cowppli‐Bony, A., Bouvier, G., Rué, M., Loiseau, H., Vital, A., Lebailly, P., Fabbro-Péray, P., & Baldi, I. (2011) · Cancer Causes & Control · doi:10.1007/s10552-011-9742-7 · Cited by 99
Kaplan, S., Novikov, L., & Modan, B. (1997) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009201 · Cited by 99
Yeung, Y. T., Bryce, N. S., Adams, S., Braidy, N., Konayagi, M., McDonald, K. L., Teo, C., Guillemin, G. J., Grewal, T., & Munoz, L. (2012) · Journal of Neuro-Oncology · doi:10.1007/s11060-012-0875-7 · Cited by 97
Melisi, D., Niu, J., Chang, Z., Xia, Q., Peng, B., Ishiyama, S., Evans, D. B., & Chiao, P. J. (2009) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-08-0201 · Cited by 95
Brito, C., Azevedo, A., Esteves, S., Marques, A. R., Martins, C., Costa, I., Mafra, M., Marques, J. B., Roque, L., & Pojo, M. (2019) · BMC Cancer · doi:10.1186/s12885-019-6177-0 · Cited by 95
Liao, L. M., Friesen, M. C., Xiang, Y., et al. (2015) · Environmental Health Perspectives · doi:10.1289/ehp.1408171 · Cited by 94
The PEPvIII-KLH (CDX-110) vaccine in glioblastoma multiforme patients
Heimberger, A. B., & Sampson, J. H. (2009) · Expert Opinion on Biological Therapy · doi:10.1517/14712590903124346 · Cited by 94
A GATA4-regulated tumor suppressor network represses formation of malignant human astrocytomas
Agnihotri, S., Wolf, A., Munoz, D. M., Smith, C. J., Gajadhar, A., Restrepo, A., Clarke, I. D., Fuller, G. N., Kesari, S., Dirks, P. B., et al. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20102099 · Cited by 92 · cited 1×
“[63] showed that: (i) in 94/163 human GBM tumor cells, GATA4 expression was lost, (ii) GATA4 inhibited transformation to GBM in vitro and in vivo, and (iii) the re-expression of GATA4 in GBM cells sensitized them to telosomide, regardless of the MGMT mutation status.”
Interleukin-1 Regulates the Expression of Sphingosine Kinase 1 in Glioblastoma Cells
Paugh, B. S., Bryan, L., Paugh, S. W., Wilczynska, K. M., Álvarez, S. M., Singh, S. K., Kapitonov, D., Rokita, H., Wright, S., Griswold‐Prenner, I., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m807170200 · Cited by 90
Chaurasia, A., Park, S., Seo, J., & Park, C. (2016) · Journal of Korean Medical Science · doi:10.3346/jkms.2016.31.8.1208 · Cited by 90
ADAMDEC1 Maintains a Growth Factor Signaling Loop in Cancer Stem Cells
Jimenez‐Pascual, A., Hale, J. S., Kordowski, A., Pugh, J., Silver, D. J., Bayık, D., Roversi, G. A., Alban, T. J., Rao, S. C., Chen, R., et al. (2019) · Cancer Discovery · doi:10.1158/2159-8290.cd-18-1308 · Cited by 90
Cannabinoids as Anticancer Drugs
Ramer, R., & Hinz, B. (2017) · Advances in pharmacology · doi:10.1016/bs.apha.2017.04.002 · Cited by 89
Lead Exposure, Polymorphisms in Genes Related to Oxidative Stress, and Risk of Adult Brain Tumors
Bhatti, P., Stewart, P. A., Hutchinson, A. A., Rothman, N., Linet, M. S., Inskip, P. D., & Rajaraman, P. (2009) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-09-0197 · Cited by 88
Coffee, Tea, Caffeine Intake, and Risk of Adult Glioma in Three Prospective Cohort Studies
Holick, C. N., Smith, S. G., Giovannucci, E. L., & Michaud, D. S. (2010) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-09-0732 · Cited by 86
Michaud, D. S., Holick, C. N., Batchelor, T. T., Giovannucci, E. L., & Hunter, D. J. (2009) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.2008.27199 · Cited by 86
Case-Control Study of Use of Nonsteroidal Antiinflammatory Drugs and Glioblastoma Multiforme
Sivak-Sears, N. R., Schwartzbaum, J., Miike, R., Moghadassi, M., & Wrensch, M. (2004) · American Journal of Epidemiology · doi:10.1093/aje/kwh153 · Cited by 83
Diabetes, use of antidiabetic drugs, and the risk of glioma
Seliger, C., Ricci, C., Meier, C. R., Bodmer, M., Jick, S. S., Bogdahn, U., Hau, P., & Leitzmann, M. F. (2015) · Neuro-Oncology · doi:10.1093/neuonc/nov100 · Cited by 82
Gousias, K., Markou, M., Voulgaris, S., Goussia, A. C., Voulgari, P. V., Bai, M. C.-W., Polyzoidis, K. S., Kyritsis, A. P., & Alamanos, Y. (2009) · Neuroepidemiology · doi:10.1159/000222090 · Cited by 81
Huber, W. W., Scharf, G., Nagel, G., Prustomersky, S., Schulte‐Hermann, R., & Kaina, B. (2003) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/s0027-5107(02)00264-6 · Cited by 81
Trends and patterns of incidence of diffuse glioma in adults in the United States, 1973‐2014
Li, K., Lu, D., Guo, Y., Wang, C., Liu, X., Liu, Y., & Liu, D. (2018) · Cancer Medicine · doi:10.1002/cam4.1757 · Cited by 81
Heavy Metals and Epigenetic Alterations in Brain Tumors
Caffo, M., Caruso, G., Fata, G. L., Barresi, V., Visalli, M., Venza, M., & Venza, I. (2015) · Current Genomics · doi:10.2174/138920291506150106151847 · Cited by 78
Rocha, F. C. M., Santos-Junior, J. G., Stefano, S. C., & da Silveira, D. X. (2013) · Journal of Neuro-Oncology · doi:10.1007/s11060-013-1277-1 · Cited by 76
Role of IL-6 in the invasiveness and prognosis of glioma.
Shan, Y., He, X., Song, W., et al. (2015) · PubMed · Cited by 73
Melatonin Inhibits Glioblastoma Stem-like cells through Suppression of EZH2-NOTCH1 Signaling Axis
Zheng, X., Pang, B., Gu, G., Gao, T., Zhang, R., Pang, Q., & Liu, Q. (2017) · International Journal of Biological Sciences · doi:10.7150/ijbs.16818 · Cited by 71
FGFR1 Induces Glioblastoma Radioresistance through the PLCγ/Hif1α Pathway
Gouazé‐Andersson, V., Delmas, C., Taurand, M., Martinez-Gala, J., Evrard, S., Mazoyer, S., Toulas, C., & Moyal, E. C. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-2058 · Cited by 69
Interleukin-1-induced changes in the glioblastoma secretome suggest its role in tumor progression
Tarassishin, L., Lim, J., Weatherly, D. B., Angeletti, R. H., & Lee, S. C. (2014) · Journal of Proteomics · doi:10.1016/j.jprot.2014.01.024 · Cited by 67
Bohn, A., Braley, A. E., de la Vega, P. R., Zevallos, J. C., & Barengo, N. C. (2018) · PLoS ONE · doi:10.1371/journal.pone.0198581 · Cited by 67
Diet and risk of glioma: combined analysis of 3 large prospective studies in the UK and USA
Kuan, A. S., Green, J., Kitahara, C. M., de González, A. B., Key, T. J., REEVES, G. K., Floud, S., Balkwill, A., Bradbury, K. E., Liao, L. M., et al. (2019) · Neuro-Oncology · doi:10.1093/neuonc/noz013 · Cited by 66
Xie, J., Yang, S., Liu, X., & Zhao, Y. (2018) · Cancer Medicine · doi:10.1002/cam4.1688 · Cited by 65
IL-1α Processing, Signaling and Its Role in Cancer Progression
Chiu, J. W., Hanafi, Z. B., Chew, L. C. Y., Mei, Y., & Liu, H. (2021) · Cells · doi:10.3390/cells10010092 · Cited by 65
Alcohol consumption and risk of glioblastoma; evidence from the Melbourne collaborative cohort study
Baglietto, L., Giles, G. G., English, D. R., Karahalios, A., Hopper, J. L., & Severi, G. (2010) · International Journal of Cancer · doi:10.1002/ijc.25770 · Cited by 63
Melatonin sensitizes human malignant glioma cells against TRAIL-induced cell death
Martín, V., García‐Santos, G., Rodríguez‐Blanco, J., Zapico, S. C., Sánchez‐Sánchez, A. M., Antolín, I., Medina, M., & Rodríguez, C. (2009) · Cancer Letters · doi:10.1016/j.canlet.2009.06.016 · Cited by 63
The effects of 2-hydroxyglutarate on the tumorigenesis of gliomas
Reiter–Brennan, C., Semmler, L., & Klein, A. (2018) · Współczesna Onkologia · doi:10.5114/wo.2018.82642 · Cited by 63
Agnihotri, S., Wolf, A., Picard, D. J., Hawkins, C. E., & Guha, A. (2009) · Oncogene · doi:10.1038/onc.2009.159 · Cited by 61
Narita, Y., & Shibui, S. (2015) · Neurologia medico-chirurgica · doi:10.2176/nmc.ra.2014-0348 · Cited by 59
Park, C.-M., Park, M.-J., Kwak, H.-J., Moon, S.-I., Yoo, D.-H., Lee, H.-C., Park, I.-C., Rhee, C. H., & Hong, S.-I. (2006) · International Journal of Oncology · doi:10.3892/ijo.28.1.119 · Cited by 58
Associations of High-Grade Glioma With Glioma Risk Alleles and Histories of Allergy and Smoking
Lachance, D. H., Yang, P., Johnson, D. R., Decker, P. A., Kollmeyer, T. M., Mccoy, L. S., Rice, T., Xiao, Y., Ali‐Osman, F., Wang, F. M., et al. (2011) · American Journal of Epidemiology · doi:10.1093/aje/kwr124 · Cited by 58
Michaud, D. S., Gallo, V., Schlehofer, B., Tjønneland, A. M., Olsen, A., Overvad, K., Dahm, C. C., Teucher, B., Lukanova, A., Boeing, H., et al. (2010) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.2010.29876 · Cited by 57
TERT mutation in glioma: Frequency, prognosis and risk
Yang, Y., Chen, Q., Maling, G., Xiang, W., Yanhui, L., Ruofei, L., Yunhe, M., Jiewen, L., & Mao, Q. (2016) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2015.05.066 · Cited by 57
Cannabinoid Signaling in Glioma Cells
Ellert‐Miklaszewska, A., Ciechomska, I. A., & Kaminska, B. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-94-007-4719-7_11 · Cited by 57
COX-2 regulates the proliferation of glioma stem like cells
Sharma, V., Dixit, D., Ghosh, S., & Sen, E. (2011) · Neurochemistry International · doi:10.1016/j.neuint.2011.06.018 · Cited by 56
And, A. M., & Mitsumori, K. (1990) · Critical Reviews in Toxicology · doi:10.3109/10408449009089866 · Cited by 55
A meta-analysis of alcohol consumption and the risk of brain tumours
Galeone, C., Malerba, S., Rota, M., Bagnardi, V., Negri, E., Scotti, L., Bellocco, R., Corrao, G., Boffetta, P., Vecchia, C. L., et al. (2012) · Annals of Oncology · doi:10.1093/annonc/mds432 · Cited by 54
Phillips, L. M., Zhou, X., Cogdell, D. E., Chua, C. Y. X., Huisinga, A., Hess, K. R., Fuller, G. N., & Zhang, W. (2016) · The Journal of Pathology · doi:10.1002/path.4734 · Cited by 54
Lam, S. K., Lin, Y., Zinn, P. O., Su, J. M. F., & Pan, I.-W. E. (2017) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2017.10.041 · Cited by 54
Fu, Y., Zheng, S., Zheng, Y., Huang, R., An, N., Liang, A., & Hu, C. (2012) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2012.01.017 · Cited by 53
Intake and food sources of nitrites and N-nitrosodimethylamine in Spain
Jakszyn, P. G., Agudo, A., Berenguer, A., Ibáñez, R., Amiano, P., Pera, G., Ardanáz, E., Barricarte, A., Chirlaque, M. D., Dorronsoro, M., et al. (2006) · Public Health Nutrition · doi:10.1079/phn2005884 · Cited by 53
Subcutaneous adipose tissue biology in metabolic syndrome
Jialal, I., & Devaraj, S. (2018) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2017-0074 · Cited by 53
The role of the PI3K/AKT/mTOR pathway in brain tumor metastasis
Crespo, S., Kind, M., & Arcaro, A. (2016) · Journal of Cancer Metastasis and Treatment · doi:10.20517/2394-4722.2015.72 · Cited by 52
ATRX, IDH1-R132H and Ki-67 immunohistochemistry as a classification scheme for astrocytic tumors
Cai, J., Zhang, C., Zhang, W., Wang, G., Yao, K., Wang, Z., Li, G., Qian, Z., Li, Y., Jiang, T., et al. (2016) · Oncoscience · doi:10.18632/oncoscience.317 · Cited by 51
Wiedmann, M. K. H., Brunborg, C., Ieva, A. D., Lindemann, K. Y., Johannesen, T. B., VATTEN, L. J., Helseth, E., & Zwart, J. (2016) · Neuro-Oncology · doi:10.1093/neuonc/now272 · Cited by 51
HMG CoA reductase inhibitors, NSAIDs and risk of glioma
Ferris, J. S., Mccoy, L. S., Neugut, A. I., Wrensch, M., & Lai, R. (2012) · International Journal of Cancer · doi:10.1002/ijc.27536 · Cited by 50
Kowalski‐Chauvel, A., Gouazé‐Andersson, V., Baricault, L., Martin, E., Delmas, C., Toulas, C., Moyal, E. C., & Seva, C. (2019) · Cancers · doi:10.3390/cancers11030406 · Cited by 50
Assessment of Type of Allergy and Antihistamine Use in the Development of Glioma
McCarthy, B. J., Rankin, K., Il’yasova, D., et al. (2011) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-10-0948 · Cited by 49
Walker, E., Davis, F. G., affiliates, C. F., Shaw, A. K., Louchini, R., Shack, L., Woods, R. R., Kruchko, C. A., Spinelli, J., Guiot, M., et al. (2018) · Neuro-Oncology · doi:10.1093/neuonc/noy195 · Cited by 49
Targeting the EGFR-family for Therapy: Biological Challenges and Clinical Perspective
Patel, R., & Leung, H. Y. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212800626148 · Cited by 45
A meta-analysis of coffee and tea consumption and the risk of glioma in adults
Malerba, S., Galeone, C., Pelucchi, C., Turati, F., Hashibe, M., Vecchia, C. L., & Tavani, A. (2012) · Cancer Causes & Control · doi:10.1007/s10552-012-0126-4 · Cited by 44
Wang, T.-J., Huang, M.-S., Hong, C.-Y., Tse, V., Silverberg, G. D., & Hsiao, M. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5565 · Cited by 44
Nonradioactive iodide effectively induces apoptosis in genetically modified lung cancer cells.
Zhang, L., Sharma, S. P., Zhu, L., Kogai, T., Hershman, J. M., Brent, G. A., Dubinett, S. M., & Huang, M. (2003) · PubMed · Cited by 44
Das, L., Patel, B., & Patri, M. (2019) · Toxicology Reports · doi:10.1016/j.toxrep.2019.10.014 · Cited by 44
on behalf of the Quality Registry Neuro Surgery glioblastoma working group from the Dutch Society of Neurosurgery, Hamer, P. C. D. W., Ho, V. K. Y., Zwinderman, A. H., Ackermans, L. P. C. M., Ardon, H., Boomstra, S., Bouwknegt, W., van den Brink, W. A., Dirven, C. M. F., et al. (2019) · Journal of Neuro-Oncology · doi:10.1007/s11060-019-03229-5 · Cited by 43
Fuentes‐Raspall, R., Solans, M., Roca-Barceló, A., Vilardell, L., Puigdemont, M., Barco, S. D., Comas, R., Garcia-Velasco, A., Astudillo, A., Carmona-Garcia, M. C., et al. (2017) · Cancer Epidemiology · doi:10.1016/j.canep.2017.07.005 · Cited by 42
Anthropometric factors in relation to risk of glioma
Little, R. B., Madden, M. H., Thompson, R. C., Olson, J. J., LaRocca, R. V., Pan, E., Browning, J. E., Egan, K. M., & Nabors, B. (2013) · Cancer Causes & Control · doi:10.1007/s10552-013-0178-0 · Cited by 41
Massi, P., Valenti, M., Solinas, M., & Parolaro, D. (2010) · Cancers · doi:10.3390/cancers2021013 · Cited by 40
Meini, A., Sticozzi, C., Massai, L., & Palmi, M. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.40 · Cited by 40
Dubrow, R., Darefsky, A. S., Freedman, N. D., Hollenbeck, A. R., & Sinha, R. R. (2012) · Cancer Causes & Control · doi:10.1007/s10552-012-9945-6 · Cited by 40
Risk of brain glioma not associated with cigarette smoking or use of other tobacco products in Iowa.
Zheng, T., Cantor, K. P., Zhang, Y., Chiu, B. C. ‐., & Lynch, C. F. (2001) · PubMed · Cited by 40
Langerhans cells and NK cells cooperate in the inhibition of chemical skin carcinogenesis
Ortner, D., Tripp, C. H., Komenda, K., Dubrac, S., Zelger, B., Hermann, M., Doppler, W., Tymoszuk, P., Boon, L., Clausen, B. E., et al. (2016) · OncoImmunology · doi:10.1080/2162402x.2016.1260215 · Cited by 40
Guo, Y., Su, Z., Zhang, C., Gaspar, J. M., Wang, R., Hart, R. P., Verzi, M. P., & Kong, A. T. (2017) · Biochemical Pharmacology · doi:10.1016/j.bcp.2017.02.021 · Cited by 40
Genetic Alterations in Primary Glioblastomas in Japan
Fukushima, T., Favereaux, A., Huang, H., Shimizu, T., Yonekawa, Y., Nakazato, Y., & Ohagki, H. (2006) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/01.jnen.0000196132.66464.96 · Cited by 39
Cited by
Mechanisms of Resistance and Current Treatment Options for Glioblastoma Multiforme (GBM)
Yalamarty, S. S. K., Filipczak, N., Li, X., Subhan, M. A., Parveen, F., Ataide, J. A., Rajmalani, B. A., & Torchilin, V. P. (2023) · Cancers · doi:10.3390/cancers15072116 · Cited by 293
Terminal anorexia nervosa cannot currently be identified
Crow, S. J. (2023) · International Journal of Eating Disorders · doi:10.1002/eat.23957 · Cited by 26
Metadata
- Authors
- Grochans, S., Cybulska, A. M., Simińska, D., Korbecki, J., Kojder, K., Chlubek, D., & Baranowska-Bosiacka, I.
- Venue
- Cancers
- Publisher
- MDPI AG
- Published
- 2022-05-13
- Volume
- 14
- Issue
- 10
- Pages
- 2412
- ISSN
- 2072-6694 (ISSN-L)
- OpenAlex
- W4280614820
- Cited by
- 630
- References
- 226
- FWCI
- 64.20
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.